Marginal Maternal Zinc Deficiency Produces Liver Damage and Altered Zinc Transporter Expression in Offspring Male Rats.
Liver markers
Maternal zinc deficiency
ZIP14
Zinc
ZnT9
Journal
Biological trace element research
ISSN: 1559-0720
Titre abrégé: Biol Trace Elem Res
Pays: United States
ID NLM: 7911509
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
received:
20
03
2023
accepted:
18
08
2023
pubmed:
1
9
2023
medline:
1
9
2023
entrez:
1
9
2023
Statut:
ppublish
Résumé
The aim of this study was to investigate how zinc deficiency and supplementation affect liver markers including autotaxin, kallistatin, endocan, and zinc carrier proteins ZIP14 and ZnT9 in rats exposed to maternal zinc deficiency. Additionally, the study aimed to assess liver tissue damage through histological examination. A total of forty male pups were included in the research, with thirty originating from mothers who were given a zinc-deficient diet (Groups 1, 2, and 3), and the remaining ten born to mothers fed a standard diet (Group 4). Subsequently, Group 1 was subjected to a zinc-deficient diet, Group 2 received a standard diet, Group 3 received zinc supplementation, and Group 4 served as the control group without any supplementation. Upon completion of the experimental phases of the study, all animals were sacrificed under general anesthesia, and samples of liver tissue were obtained. The levels of autotaxin, kallistatin, endocan, ZIP 14, and ZnT9 in these liver tissue samples were determined using the ELISA technique. In addition, histological examination was performed to evaluate tissue damage in the liver samples. In the group experiencing zinc deficiency, both endocan and autotaxin levels increased compared to the control group. With zinc supplementation, the levels of endocan and autotaxin returned to the values observed in the control group. Similarly, the suppressed levels of kallistatin, ZIP14, and ZnT9 observed in the zinc deficiency group were reversed with zinc supplementation. Likewise, the reduced levels of kallistatin, ZIP14, and ZnT9 seen in the zinc deficiency group were rectified with zinc supplementation. Moreover, the application of zinc partially ameliorated the heightened liver tissue damage triggered by zinc deficiency. This study is the pioneering one to demonstrate that liver tissue dysfunction induced by a marginal zinc-deficient diet in rats with marginal maternal zinc deficiency can be alleviated through zinc supplementation.
Identifiants
pubmed: 37656390
doi: 10.1007/s12011-023-03824-8
pii: 10.1007/s12011-023-03824-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2133-2142Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Baltaci AK, Mogulkoc R, Baltaci SB (2019) Review: the role of zinc in the endocrine system. Pak J Pharm Sci 32(1):231–239
pubmed: 30772815
Katayama K (2020) Zinc and protein metabolism in chronic liver diseases. Nutr Res 74:1–9
pubmed: 31891865
doi: 10.1016/j.nutres.2019.11.009
Yang W, Wang X, Yu Z, Li C, Sun M, Li Y, Hui Y, Guo G, Fan X, Jiang K, Sun C (2022) Low levels of serum zinc associate with malnutrition risk assessed by the royal free hospital-nutritional prioritizing tool in cirrhosis. Biol Trace Elem Res 200(10):4289–4296
pubmed: 34791623
doi: 10.1007/s12011-021-03033-1
Jimenez-Rondan FR, Ruggiero CH, McKinley KL, Koh J, Roberts JF, Triplett EW, Cousins RJ (2023) Enterocyte-specific deletion of metal transporter Zip14 (Slc39a14) alters intestinal homeostasis through epigenetic mechanisms. Am J Physiol Gastrointest Liver Physiol 324(3):G159–G176
pubmed: 36537699
doi: 10.1152/ajpgi.00244.2022
Aydemir TB, Troche C, Kim MH, Cousins RJ (2016) Hepatic ZIP14-mediated zinc transport contributes to endosomal ınsulin receptor trafficking and glucose metabolism. J Biol Chem 291(46):23939–23951
pubmed: 27703010
pmcid: 5104920
doi: 10.1074/jbc.M116.748632
Maxel T, Smidt K, Larsen A, Bennetzen M, Cullberg K, Fjeldborg K, Lund S, Pedersen SB, Rungby J (2015) Gene expression of the zinc transporter ZIP14 (SLC39a14) is affected by weight loss and metabolic status and associates with PPARγ in human adipose tissue and 3T3-L1 pre-adipocytes. BMC Obes 2:46
pubmed: 26623077
pmcid: 4657294
doi: 10.1186/s40608-015-0076-y
Costello LC, Franklin RB (2014) The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship. Cancer Biol Ther 15(4):353–360
pubmed: 24448510
pmcid: 3979811
doi: 10.4161/cbt.27633
Gartmann L, Wex T, Grüngreiff K, Reinhold D, Kalinski T, Malfertheiner P, Schütte K (2018) Expression of zinc transporters ZIP4, ZIP14 and ZnT9 in hepatic carcinogenesis-an immunohistochemical study. J Trace Elem Med Biol 49:35–42
pubmed: 29895370
doi: 10.1016/j.jtemb.2018.04.034
She S, Zhang Q, Shi J, Yang F, Dai K (2022) Roles of autotaxin/autotaxin-lysophosphatidic acid axis in the ınitiation and progression of liver cancer. Front Oncol 12:922945
pubmed: 35769713
pmcid: 9236130
doi: 10.3389/fonc.2022.922945
Zhang X, Li M, Yin N, Zhang J (2021) The expression regulation and biological function of autotaxin. Cells 10(4):939
pubmed: 33921676
pmcid: 8073485
doi: 10.3390/cells10040939
Peyruchaud O, Saier L, Leblanc R (2019) Autotaxin ımplication in cancer metastasis and autoimunne disorders: functional ımplication of binding autotaxin to the cell surface. Cancers (Basel) 12(1):105
pubmed: 31906151
doi: 10.3390/cancers12010105
Ando W, Kaneko F, Shimamoto S, Igarashi K, Otori K, Yokomori H (2022) Long-term prediction of hepatocellular carcinoma using serum autotaxin levels after antiviral therapy for hepatitis C. Ann Hepatol 27(2):100660
pubmed: 35007770
doi: 10.1016/j.aohep.2022.100660
Thomson CG, Le Grand D, Dowling M, Brocklehurst CE, Chinn C, Elphick L, Faller M, Freeman M, Furminger V, Gasser C, Hamadi A, Hardaker E, Head V, Hill JC, Janus DI, Pearce D, Poulaud AS, Stanley E, Sviridenko L (2018) Development of autotaxin inhibitors: a series of zinc binding triazoles. Bioorg Med Chem Lett 28(13):2279–2284
pubmed: 29798825
doi: 10.1016/j.bmcl.2018.05.030
Nikolaou A, Ninou I, Kokotou MG, Kaffe E, Afantitis A, Aidinis V, Kokotos G (2018) Hydroxamic acids constitute a novel class of autotaxin ınhibitors that exhibit in vivo efficacy in a pulmonary fibrosis model. J Med Chem 61(8):3697–3711
pubmed: 29620892
doi: 10.1021/acs.jmedchem.8b00232
Frühbeck G, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Valentí V, Moncada R, Becerril S, Unamuno X, Silva C, Salvador J, Catalán V (2018) Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress. Metabolism 87:123–135
pubmed: 29679615
doi: 10.1016/j.metabol.2018.04.004
Lin WC, Chen CW, Huang YW, Chao L, Chao J, Lin YS, Lin CF (2015) Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Sci Rep 5:12463
pubmed: 26198099
pmcid: 4510498
doi: 10.1038/srep12463
Chen LM, Chao L, Chao J (1997) Beneficial effects of kallikrein-binding protein in transgenic mice during endotoxic shock. Life Sci 60(17):1431–1435
pubmed: 9126863
doi: 10.1016/S0024-3205(97)00094-5
Li P, Guo Y, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J (2015) Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis. Crit Care 19(1):200
pubmed: 25930108
pmcid: 4445990
doi: 10.1186/s13054-015-0919-4
Wahb AMSE, El Kassas M, Khamis AK, Elhelbawy M, Elhelbawy N, Habieb MSE (2021) Circulating microRNA 9-3p and serum endocan as potential biomarkers for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol 13(11):1753–1765
pubmed: 34904043
pmcid: 8637686
doi: 10.4254/wjh.v13.i11.1753
Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C, Lortat-Jacob H, Bechard D, Lassalle P, Delehedde M (2006) Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 1765:25–37
pubmed: 16168566
Leroy X, Aubert S, Zini L, Franquet H, Kervoaze G, Villers A, Delehedde M, Copin MC, Lassalle P (2010) Vascular endocan (ESM-1) is markedly overexpressed in clear cell renal cell carcinoma. Histopathology 56(2):180–187
pubmed: 20102396
doi: 10.1111/j.1365-2559.2009.03458.x
Goktepe E, Baltaci SB, Unal O, Unlukal N, Mogulkoc R, Baltaci AK (2023) The relationship between beta cell activation and SLC30A8/ZnT8 levels of the endocrine pancreas and maternal zinc deficiency in rats. J Trace Elem Med Biol 79:127217
pubmed: 37224745
doi: 10.1016/j.jtemb.2023.127217
Unal O (2022) The relationship of zinc deficiency and zinc administration with pubertal parameters, behavioral changes, and cognitive functions in male pups of pregnant rats fed zinc-deficient diet. Republıc of Turkey Selcuk Unıversity Institute Of Health Sciences Department of Physiology PhD Thesis, pp 38–39
Omar SA, Attia NM, Sheir MI, Amer AS, El Shabrawy MM, Hasan BB (2021) Is serum endocan a sensitive biomarker for early recurrence of hepatocellular carcinoma after radiofrequency ablation? Eur J Gastroenterol Hepatol 33(7):1015–1022
pubmed: 33867440
doi: 10.1097/MEG.0000000000002074
Dallio M, Masarone M, Caprio GG, Di Sarno R, Tuccillo C, Sasso FC, Persico M, Loguercio C, Federico A (2017) Endocan serum levels in patients with non-alcoholic fatty liver disease with or without type 2 diabetes mellitus: a pilot study. J Gastrointestin Liver Dis 26(3):261–268
pubmed: 28922438
doi: 10.15403/jgld.2014.1121.263.dal
Qiu H, Song E, Hu Y, Li T, Ku KC, Wang C, Cheung BMY, Cheong LY, Wang Q, Wu X, Hoo RLC, Wang Y, Xu A (2022) Hepatocyte-secreted autotaxin exacerbates nonalcoholic fatty liver disease through autocrine ınhibition of the PPARα/FGF21 axis. Cell Mol Gastroenterol Hepatol S2352-345X(22):00170–00179
Booijink R, Salgado-Polo F, Jamieson C, Perrakis A, Bansal R (2022) A type IV autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis. EMBO Mol Med 14(9):e16333
pubmed: 35833384
pmcid: 9449594
doi: 10.15252/emmm.202216333
Shashidhar KN, Lakshmaiah V, Muninarayana C, Nallagangula KS (2021) Quantitative ELISA for SERPINA4/kallistatin. Biotechniques 71(5):556–565
pubmed: 34528838
doi: 10.2144/btn-2018-0194
Kularaj SS, Verma SK, Kumar V, Patwa AK, Chaudhary SC, Sonkar SK, Gupta KK, Atam V, Verma SK, Bhosale V, Singh S (2022) Serum kallistatin as a marker of severity of liver fibrosis in cirrhosis: a cross-sectional observational study. J Family Med Prim Care 11(5):2129–2133
pubmed: 35800506
pmcid: 9254775
doi: 10.4103/jfmpc.jfmpc_1922_21
Bloom A, Bloom S, Silva H, Nicoll AJ, Sawhney R (2021) Zinc supplementation and its benefits in the management of chronic liver disease: an in-depth literature review. Ann Hepatol 2021:100549
doi: 10.1016/j.aohep.2021.100549
Coni P, Pichiri G, Lachowicz JI, Ravarino A, Ledda F, Fanni D, Gerosa C, Piras M, Coghe F, Gibo Y, Cau F, Castagnola M, Van Eyken P, Saba L, Piludu M, Faa G (2021) Zinc as a Drug for Wilson’s disease, Non-Alcoholic Liver Disease and COVID-19 Related Liver Injury. Molecules 26(21):6614
pubmed: 34771023
pmcid: 8587580
doi: 10.3390/molecules26216614
Iritani S, Kawamura Y, Muraishi N, Fujiyama S, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Arase Y, Ikeda K, Suzuki Y, Kumada H (2022) The useful predictors of zinc deficiency for the management of chronic liver disease. J Gastroenterol 57(4):322–332
pubmed: 35233650
doi: 10.1007/s00535-022-01852-0
Tsuchiya H (2022) Gustatory and saliva secretory dysfunctions in COVID-19 patients with zinc deficiency. Life (Basel) 12(3):353
pubmed: 35330104
Bitirim CV (2021) The role of zinc transporter proteins as predictive and prognostic biomarkers of hepatocellular cancer. Peer J 9:e12314
pubmed: 34721988
pmcid: 8522644
doi: 10.7717/peerj.12314
Kim MH, Aydemir TB, Kim J, Cousins RJ (2017) Hepatic ZIP14-mediated zinc transport is required for adaptation to endoplasmic reticulum stress. Proc Natl Acad Sci U S A 114(29):E5805–E5814
pubmed: 28673968
pmcid: 5530682
doi: 10.1073/pnas.1704012114
Wessels I, Cousins RJ (2015) Zinc dyshomeostasis during polymicrobial sepsis in mice involves zinc transporter Zip14 and can be overcome by zinc supplementation. Am J Physiol Gastrointest Liver Physiol 309(9):G768–G778
pubmed: 26272258
pmcid: 4628964
doi: 10.1152/ajpgi.00179.2015
Sun Q, Li Q, Zhong W, Zhang J, Sun X, Tan X, Yin X, Sun X, Zhang X, Zhou Z (2014) Dysregulation of hepatic zinc transporters in a mouse model of alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 307(3):G313–G322
pubmed: 24924749
pmcid: 4121635
doi: 10.1152/ajpgi.00081.2014
Aydemir TB, Sitren HS, Cousins RJ (2012) The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice. Gastroenterology 142(7):1536–46.e5
pubmed: 22374166
doi: 10.1053/j.gastro.2012.02.046
Franklin RB, Levy BA, Zou J, Hanna N, Desouki MM, Bagasra O, Johnson LA, Costello LC (2012) ZIP14 zinc transporter downregulation and zinc depletion in the development and progression of hepatocellular cancer. J Gastrointest Cancer 43(2):249–257
pubmed: 21373779
pmcid: 3724761
doi: 10.1007/s12029-011-9269-x
Mohammad MK, Zhou Z, Cave M, Barve A, McClain CJ (2012) Zinc and liver disease. Nutr Clin Pract 27(1):8–20
pubmed: 22307488
doi: 10.1177/0884533611433534
Goode HF, Kelleher J, Walker BE (1990) Relation between zinc status and hepatic functional reserve in patients with liver disease. Gut 31(6):694–697
pubmed: 2379875
pmcid: 1378499
doi: 10.1136/gut.31.6.694
Zhang C, Lu X, Tan Y, Li B, Miao X, Jin L, Shi X, Zhang X, Miao L, Li X, Cai L (2012) Diabetes-induced hepatic pathogenic damage, inflammation, oxidative stress, and insulin resistance was exacerbated in zinc deficient mouse model. PLoS One 7(12):e49257
pubmed: 23251339
pmcid: 3520990
doi: 10.1371/journal.pone.0049257
Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, Kang YJ (2005) Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress. Am J Pathol 166(6):1681–1690
pubmed: 15920153
pmcid: 1602418
doi: 10.1016/S0002-9440(10)62478-9
Kang X, Zhong W, Liu J, Song Z, McClain CJ, Kang YJ, Zhou Z (2009) Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. Hepatology 50(4):1241–1250
pubmed: 19637192
doi: 10.1002/hep.23090